Non-alcoholic fatty liver disease (NAFLD) is a serious health problem due to its high
incidence and consequences. In view of the existing controversies, new therapeutic options …

Patients with chronic kidney disease (CKD) and dialysis have higher mortality than those
without, and cardiovascular disease (CVD) is the main cause of death. As CVD is caused by …

There is consistent evidence that vitamin D deficiency is strongly associated with liver
dysfunction, disease severity, and poor prognosis in patients with liver disease. Vitamin D …

Background The association between serum 25-hydroxyvitamin D [25 (OH) D]
concentrations and mortality among patients with metabolic dysfunction–associated fatty …

Abstract Type 1 diabetes (T1D) and latent autoimmune diabetes in adults (LADA) represent
the most common types of autoimmune diabetes and are characterized by different age of …

Background Eccentric exhaustive exercise (EEE) training has been known as a promising
training modality to enhance performance and stimulate adaptation in healthy individuals or …

Background: Hashimoto's thyroiditis (HT) is the prevailing form of autoimmune thyroiditis and
the leading cause of hypothyroidism in iodine-sufficient regions worldwide. This study aims …

Background The prevalence of non‐alcohol‐related fatty liver disease (NAFLD) varies
between 19% and 33% in different populations. NAFLD decreases life expectancy and …

Background Emerging treatment methods, including exercise, diet, and drugs, for
nonalcoholic fatty liver disease have been proposed. However, the differences in their …

Evidence from preclinical and clinical studies for the role of vitamin D in non-alcoholic fatty
liver disease (NAFLD) pathogenesis is conflicting. Although microRNAs (miRNAs) are …